Magazine Article | January 4, 2021

What I Learned Running A Biotech During The Pandemic

Source: Life Science Leader

By Sven Karlsson

As I biked home from PlateletBio’s new offices in Watertown, MA, last March, I was excited about all we planned to accomplish in 2020. We had recently raised more than $80 million in venture funding and non-dilutive grants, built our own lab, and had ambitious plans for 2020. We were hiring and laying the groundwork for upcoming clinical trials for our new class of cell therapeutics inspired by platelet biology.

Then … wham! The pandemic hit, and we didn’t know if we could even go into our new lab. As cofounder and COO, I was tasked with finding a way to make progress on our 2020 milestones while ensuring that we all stayed safe.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: